# OnCo record nec-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nec-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nec-bio" ;
  schema:name "NEC Bio"@en ;
  schema:alternateName "NEC Bio B.V."@en, "NEC OncoImmunity"@en, "NEC Bio Therapeutics"@en ;
  schema:description "NEC Bio is a Netherlands-based biotechnology company that leads 2 cancer trials in OnCo, testing the personalised neoantigen vaccine NECVAX-NEO1 in triple-negative breast cancer and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/nec-bio/>, <https://www.nec-bio.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.nec-bio.com/>, <https://clinicaltrials.gov/search?lead=NEC%20Bio%20B.V> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "NL" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:trials <https://onco.cc/trials/nct06631079/>, <https://onco.cc/trials/nct06631092/> .